Form 4: Korro Bio Investor Edward Mathers Acquires $56 Worth of Common Stock

Edward Mathers, a director of Korro Bio, Inc., acquired 17,857 shares of common stock at $56 per share on April 22, 2024, pursuant to a subscription agreement.

Summary

• On April 22, 2024, Edward Mathers, a director of Korro Bio, Inc., purchased 17,857 shares of common stock at a price of $56 per share.
• The transaction was made pursuant to a subscription agreement dated April 17, 2024.
• Following the transaction, Mathers indirectly owns 1,090,793 shares through his role as a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P., which is the sole general partner of New Enterprise Associates 17, L.P. ('NEA 17').
• Mathers disclaims beneficial ownership of the securities held by NEA 17, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The purchase of shares by a director could be seen as slightly positive, but the amount is not significant enough to drastically alter sentiment.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. This provides transparency to the market.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• The size of this transaction is relatively small compared to overall institutional holdings, but it is still a relevant disclosure.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates